FDA Brief

Warning letters Drugs

FDA warning letter to

Walmart, Inc.

High riskIssued Oct 1Posted Oct 6Center for Drug Evaluation and Research (CDER)

Walmart sold three unapproved drugs for genital herpes and sores on walmart.com, FDA says.

What happened

FDA bought "HClear for him," "Herstat GST" and "Terragen HG Formula" through www.walmart.com in July 2026 and reviewed their labeling. The labels claim the products relieve genital herpes outbreaks and genital sores, which makes them drugs, and FDA said none has an approved application. Walmart shipped the products to individual U.S. consumers through Walmart Fulfillment Services on behalf of third-party sellers.

What FDA found

  1. The labels claim the products treat genital herpes and genital sores, so they are drugs under the law.

    Section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 321(g)(1)
  2. The products are not generally recognized as safe and effective for these uses, and no FDA-approved application is in effect for any of them.

    Sections 201(p) and 505(a) of the FD&C Act, 21 U.S.C. 321(p) and 355(a)
  3. Selling these unapproved new drugs across state lines is illegal.

    Sections 301(d) and 505(a) of the FD&C Act, 21 U.S.C. 331(d) and 355(a)
  4. Herstat GST claims relief of genital sores, which goes beyond the uses allowed for external pain relievers sold without approval, so it fits no allowed over-the-counter category.

    Section 505G of the FD&C Act; OTC Monograph M017
  5. HClear for him is labeled homeopathic but lists lemongrass 2X HPUS, which is not listed in the Homeopathic Pharmacopeia of the United States as an active ingredient, so it falls outside FDA's homeopathic guidance.

    Homeopathic Drug Products: Guidance for FDA Staff and Industry (December 2022)
  6. Being labeled homeopathic does not exempt a product from drug approval, adulteration or misbranding rules.

    Section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)

What FDA wants

FDA tells Walmart to find the root causes, fix them and prevent repeat violations, and to send a written response with the steps taken and supporting documents within 15 business days.

Who should pay attention

  • online marketplaces that ship and fulfill products for third-party sellers
  • sellers listing products that claim to relieve infection symptoms
  • retailers and buyers sourcing over-the-counter or homeopathic items for genital conditions

This is a summary. Read the original letter on fda.gov.

Walmart, Inc.'s FDA history

  1. Walmart, Inc.

    Infant Botulism Outbreak

  2. Walmart, Inc.

    Finished Pharmaceuticals/Unapproved New Drugs

  3. Walmart, Inc

    Unapproved New Drugs/Misbranded

  4. Walmart Inc.

    Finished Pharmaceuticals/Unapproved New Drug/Misbranded

Full company page

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk